Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effects of streptozotocin treatment on several kinases that can phosphorylate tau. Effects of streptozotocin treatment on several kinases that can phosphorylate.

Published byLasse Dideriksen Modified over 5 years ago

Similar presentations

Presentation on theme: "Effects of streptozotocin treatment on several kinases that can phosphorylate tau. Effects of streptozotocin treatment on several kinases that can phosphorylate."— Presentation transcript:

1 Effects of streptozotocin treatment on several kinases that can phosphorylate tau.
Effects of streptozotocin treatment on several kinases that can phosphorylate tau. Mice were treated with streptozotocin (S), and after 3 days, cerebral cortex protein extracts were immunoblotted for phospho–Ser9-GSK3β, total GSK3β, Cdk5 (p35 and p25 catalytic subunits), phospho–Thr202,Tyr204-ERK1/2, total ERK1/2, phospho–Thr180,Tyr182-p38, total p-38, phospho–Thr183,Tyr185-JNK, and total JNK. C, control; S, streptozotocin treated. Buffie J. Clodfelder-Miller et al. Diabetes 2006;55: ©2006 by American Diabetes Association

Download ppt "Effects of streptozotocin treatment on several kinases that can phosphorylate tau. Effects of streptozotocin treatment on several kinases that can phosphorylate."

Similar presentations

Fig. 5. Agmatine suppressed JNK and P38 MAPK phosphorylation after TBI

Fig. 5. Agmatine suppressed JNK and P38 MAPK phosphorylation after TBI
PI 3-kinase inhibition has no effect on ANG II induced extracellular recognition kinase (ERK) 1/2 activation. PI 3-kinase inhibition has no effect on ANG.

PI 3-kinase inhibition has no effect on ANG II induced extracellular recognition kinase (ERK) 1/2 activation. PI 3-kinase inhibition has no effect on ANG.
The amino‐terminal regulatory domain of Mcl1.

The amino‐terminal regulatory domain of Mcl1.
Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.

Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.
AZD9291 inhibits EGFR phosphorylation and downstream signaling in murine models of EGFRT790M-resistant lung cancer. AZD9291 inhibits EGFR phosphorylation.

AZD9291 inhibits EGFR phosphorylation and downstream signaling in murine models of EGFRT790M-resistant lung cancer. AZD9291 inhibits EGFR phosphorylation.
1,25‐dihydroxyvitamin D3 and retinoic acid induce p19ink4d expression.

1,25‐dihydroxyvitamin D3 and retinoic acid induce p19ink4d expression.
CDK4 is required for the hormone-independent growth of ER+ breast cancer cells. CDK4 is required for the hormone-independent growth of ER+ breast cancer.

CDK4 is required for the hormone-independent growth of ER+ breast cancer cells. CDK4 is required for the hormone-independent growth of ER+ breast cancer.
PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation. PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation.

PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation. PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation.
Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.

Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.
PGAM5 associates with and activates ASK1.

PGAM5 associates with and activates ASK1.
Volume 92, Issue 5, Pages (March 1998)

Volume 92, Issue 5, Pages (March 1998)
Insulin content of isolated pancreas and islet morphology.

Insulin content of isolated pancreas and islet morphology.
INT-767 treatment prevents the increase in renal HIF and Glut1 expression and ER stress in diabetic DBA/2J mice. INT-767 treatment prevents the increase.

INT-767 treatment prevents the increase in renal HIF and Glut1 expression and ER stress in diabetic DBA/2J mice. INT-767 treatment prevents the increase.
PAR-1 for the Course of Neurodegeneration

PAR-1 for the Course of Neurodegeneration
NF1 downregulation activates MAPK pathway signaling.

NF1 downregulation activates MAPK pathway signaling.
Immunohistochemical analysis.

Immunohistochemical analysis.
Fig. 6. FGFR1 and CCND1 amplification–mediated resistance to estrogen deprivation is therapeutically actionable. FGFR1 and CCND1 amplification–mediated.

Fig. 6. FGFR1 and CCND1 amplification–mediated resistance to estrogen deprivation is therapeutically actionable. FGFR1 and CCND1 amplification–mediated.
Nec‐1 inhibits the phosphorylation and aggregation of tau

Nec‐1 inhibits the phosphorylation and aggregation of tau
Time course of phosphorylation changes at Ser-293, Ser-300, and Ser-232 in PDHE1α following kinase inhibition with DCA. A, relative quantitation over three.

Time course of phosphorylation changes at Ser-293, Ser-300, and Ser-232 in PDHE1α following kinase inhibition with DCA. A, relative quantitation over three.
Figure 4. p38α mitogen-activated protein kinase (MAPK) blockade reduces interstitial volume in obstructed kidneys but does not reduce the number of infiltrating.

Figure 4. p38α mitogen-activated protein kinase (MAPK) blockade reduces interstitial volume in obstructed kidneys but does not reduce the number of infiltrating.

Similar presentations

Ads by Google